M. Mclaren

发表

Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with Type 1 diabetes with no clinical vascular disease

S. Greene, R. Newton, T. Elhadd, 1999, Diabetes/metabolism research and reviews.

The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.

M. Mclaren, D. Darko, M. Seed, 2000, Family practice.

Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms.

Gwen Kennedy, G. Kennedy, A. Hill, 2005, Free radical biology & medicine.

Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial.

J. Barbenel, C. Forbes, M. Mclaren, 1983, British journal of clinical pharmacology.

The use of Ginkgo biloba in Raynaud’s disease: a double-blind placebo-controlled trial

M. Mclaren, J. Belch, F. Daly, 2002, Vascular medicine.

Elevated Plasma Vascular Endothelial Cell Growth Factor and Thrombomodulin in Juvenile Diabetic Patients

T. Elhadd, M. Mclaren, J. Belch, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Dietary supplementation with omega 3 and omega 6 fatty acids reduces induced white blood cell aggregation in healthy volunteers.

M. Mclaren, J. Belch, C. Maple, 1998, Prostaglandins, leukotrienes, and essential fatty acids.

Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.

C. Forbes, I. Greer, M. Mclaren, 1986, Thrombosis research.

A Comparative Study of Captopril and Enalapril on Endothelial Cell Function in Congestive Heart Failure Patients

M. Mclaren, J. Belch, A. Bridges, 1995, Angiology.

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

Dinh Q. Phung, C. A. Shaw, M. Kumar, 2021, The Lancet Oncology.

Dark chocolate inhibits platelet aggregation in healthy volunteers

G. Kennedy, M. Mclaren, J. Belch, 2003, Platelets.

Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon.

D. Veale, M. Mclaren, J. Belch, 1997, Arthritis and rheumatism.

Investigation of platelet glycoprotein IIIa polymorphism using flow cytometry in patients with rheumatoid arthritis

A. Rudd, M. Mclaren, J. Belch, 2005, Scandinavian journal of rheumatology.

Activated factor XII in rheumatoid arthritis

M. Mclaren, J. Belch, J. Belch, 2001, Rheumatology International.

Irish society for rheumatology

I. Bruce, M. Goggins, B. Bresnihan, 1994 .

Haemostatic Effects of Ketorolac with and without Concomitant Heparin in Normal Volunteers

C. Forbes, I. Greer, R. Bullingham, 1988, Thrombosis and Haemostasis.

Inhibition of thromboxane and prostacyclin production in whole blood by adrenoceptor antagonists.

C. Forbes, I. Greer, M. Mclaren, 1985, Prostaglandins, leukotrienes, and medicine.

Fibrinolytic response to venous occlusion in diabetics with and without microangiopathy compared to normal age and sex matched controls

C. Forbes, M. Mclaren, J. Belch, 1990 .

Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.

J. Oxtoby, R. Clayton, T. Elhadd, 2001, The Journal of clinical endocrinology and metabolism.

Endothelial Cell and Platelet Function in Marfan's Syndrome

M. Mclaren, J. Belch, J. Gray, 1993 .

A circadian variation exists for soluble levels of intercellular adhesion molecule-1 and E-selectin in healthy volunteers.

D. Veale, M. Mclaren, J. Belch, 1998, Clinical science.

Prothrombotic effect of erythropoietin in dialysis patients.

M. Mclaren, J. Belch, W. K. Stewart, 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Influence of puberty on endothelial dysfunction and oxidative stress in young patients with type 1 diabetes.

S. Greene, R. Newton, T. Elhadd, 1998, Diabetes care.

The Relationship of Oxidative Stress to Thrombotic Tendency in Type 1 Diabetic Patients with Retinopathy

M. Mclaren, N. Scott, A. Saniabadi, 1991, Diabetic medicine : a journal of the British Diabetic Association.

Vascular endothelial growth factor in patients with critical limb ischemia before and after amputation.

M. Mclaren, J. Belch, F. Khan, 2002, International angiology : a journal of the International Union of Angiology.

Increased platelet activation in renal transplant patients.

M. Mclaren, J. Belch, S. Heptinstall, 1999, Platelets.

Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients.

M. Mclaren, W. K. Stewart, I. Henderson, 1993, Kidney international.

Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.

C. Lau, M. Mclaren, J. Belch, 1993, Annals of the rheumatic diseases.

Circadian variation in vascular tone and endothelial cell function in normal males.

G. Kennedy, M. Mclaren, J. Belch, 2002, Clinical science.

Baseline plasma fibrinolysis and its correlation with clinical manifestations in patients with Raynaud's phenomenon.

C. Lau, M. Mclaren, I. Mackay, 1993, Annals of the rheumatic diseases.

Effects of fish oil on plasma fibrinolysis in patients with mild rheumatoid arthritis.

C. Lau, M. Mclaren, J. Belch, 1995, Clinical and Experimental Rheumatology.

Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.

T. Pringle, G. Mcneill, M. Mclaren, 1993, British heart journal.

Effect of dialyzer geometry during hemodialysis with cuprophane membranes.

M. Mclaren, J. Belch, R. Mactier, 1992, Kidney international.

Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer.

E. Abel, M. Mclaren, J. Belch, 2000, Platelets.

Seasonal variation in fibrinolysis in patients with rheumatoid arthritis

C. Forbes, C. Lau, M. Mclaren, 1990 .

Endothelial dysfunction in acute myocardial infarction after reperfusion.

T. Pringle, M. Mclaren, J. Belch, 1993, American heart journal.

Immunoreactive prostacyclin and thromboxane metabolites in normal pregnancy and the puerperium

C. Forbes, I. Greer, M. Mclaren, 1985, British journal of obstetrics and gynaecology.

A PROSPECTIVE LONGITUDINAL STUDY OF IMMUNOREACTIVE PROSTACYCLIN AND THROMBOXANE METABOLITES IN NORMAL AND HYPERTENSIVE PREGNANCY

C. Forbes, I. Greer, M. Mclaren, 1985 .

Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease (PAOD).

M. Mclaren, J. Belch, P. Stonebridge, 1999, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Respiratory dysfunction and white cell activation following cardiopulmonary bypass: comparison of membrane and bubble oxygenators.

M. Mclaren, J. Belch, D. Wheatley, 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

A Comparative Study Using Immunological and Biological Assays of the Haemostatic Responses to DDAVP Infusion Venous Occlusion and Exercise in Normal Men

C. Prowse, I. Macgregor, M. Mclaren, 1984, Thrombosis and Haemostasis.

The effects of thromboxane receptor blockade on platelet aggregation and digital skin blood flow in patients with secondary Raynaud's syndrome

C. Lau, M. Mclaren, J. Belch, 2004, Rheumatology International.

Does Non-Acetylated Salicylate Inhibit Thromboxane Biosynthesis in Human Platelets?

C. Forbes, G. Lowe, R. Russell, 1988, Scottish medical journal.

Endothelium II: inflammatory response

G. Kennedy, M. Mclaren, 2005 .

The effects of intravenous ZK36-374, a stable prostacyclin analogue, on normal volunteers.

C. Forbes, I. Greer, M. Mclaren, 1984, Prostaglandins.

Iloprost and risk of thromboembolism.

C. Forbes, C. Lau, M. Mclaren, 1991, The American journal of medicine.

Seasonal variation in plasma levels of endothelin-1 and nitric oxide.

M. Mclaren, J. Belch, C. Bolton-Smith, 2000, International angiology : a journal of the International Union of Angiology.

LABETALOL AND PLATELET FUNCTION IN PRE-ECLAMPSIA

C. Forbes, M. Mclaren, J. Belch, 1982, The Lancet.

Umbilical artery perfusion: A method to measure prostacyclin production in vitro

C. Forbes, I. Greer, M. Mclaren, 1986 .

Clinical implications of soluble intercellular adhesion molecule-1 levels in systemic sclerosis.

D. Veale, M. Mclaren, J. Belch, 1998, British journal of rheumatology.

Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage.

P. McCollum, D. Harrison, A. Hill, 1994, Advances in experimental medicine and biology.

Uterine activity in spontaneous labour and maternal peripheral plasma prostaglandin E 2 and F 2alpha metabolites

M. Mclaren, A. Calder, G. Phillips, 1993, Journal of perinatal medicine.

Is chronic fatigue syndrome associated with platelet activation?

G. Kennedy, M. Mclaren, J. Belch, 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Soluble P-selectin assay: importance of correct anticoagulant choice.

M. Mclaren, J. Belch, G. Kirk, 1997, Platelets.

Short Communication: Platelet Aggregation in Whole Blood: Comparison Between Clay Adams Ultra-FLO 100 and Coulter Haematology Analyser T-540.

M. Mclaren, J. Belch, A. Bancroft, 1990, Platelets.

A study of whole blood platelet and white cell aggregation using a laser flow aggregometer

E. Abel, M. Mclaren, J. Belch, 2003, Platelets.

Soluble cell adhesion molecules--P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis.

D. Veale, M. Mclaren, J. Belch, 1998, Scandinavian journal of rheumatology.

Short Communication: A Circadian Rhythm may Exist in Healthy Controls for Soluble P-Selectin and Platelet Count.

M. Mclaren, J. Belch, G. Kirk, 1995, Platelets.

Synergistic inhibitory effects of adrenoceptor antagonists and prostacyclin, and umbilical artery-derived prostacyclin-like activity on platelet aggregation.

C. Forbes, I. Greer, M. Mclaren, 1990, European journal of obstetrics, gynecology, and reproductive biology.

A Comparative Study of the Effects of Adrenoceptor Antagonists on Platelet Aggregation and Thromboxane Generation

C. Forbes, I. Greer, M. Mclaren, 1985, Thrombosis and Haemostasis.

Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis.

C. Lau, M. Mclaren, A. Saniabadi, 1993, Scandinavian journal of rheumatology.

Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease.

B. McGorum, J. Keen, M. Mclaren, 2010, Equine veterinary journal.

The Effect of Endralazine and Hydralazine on Platelet Thromboxane Production in Vitro

C. Forbes, I. Greer, M. Mclaren, 1987 .

Endothelin‐1 levels predict 3‐year survival in patients who have amputation for critical leg ischaemia

G. Kennedy, M. Mclaren, F. Khan, 2005, The British journal of surgery.

Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.

C. Lau, M. Mclaren, J. Belch, 1991, British journal of rheumatology.

The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty.

J. W. Shaw, M. Mclaren, J. Belch, 1997, Circulation.

T-type and L-type calcium currents in freshly dispersed human uterine smooth muscle cells.

L. Smith, R. Young, M. Mclaren, 1993, American journal of obstetrics and gynecology.

Elevated Levels of sE-selectin in Post-menopausal Females Are Decreased by Hormone Replacement Therapy to Levels Observed in Pre-menopausal Females

G. Kennedy, M. Mclaren, J. Belch, 1999, Thrombosis and Haemostasis.

Decrease in P-selectin levels in patients with hypercholesterolaemia and peripheral arterial occlusive disease after lipid-lowering treatment

M. Mclaren, J. Belch, P. Stonebridge, 1999, Vascular medicine.

Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study

A. Struthers, M. Mclaren, R. Macfadyen, 2004, Heart.

The inflammatory process in intermittent claudication

M. Mclaren, J. Belch, F. Khan, 2002 .

Endothelial integrity, soluble adhesion molecules and platelet markers in Type 1 diabetes mellitus.

R. Newton, T. Elhadd, M. Mclaren, 1999, Diabetic medicine : a journal of the British Diabetic Association.

Vaginal Administration of PGE2 for Induction of Labor Stimulates Endogenous PGF2a Production

I. Greer, M. Mclaren, A. Calder, 1990, Acta obstetricia et gynecologica Scandinavica.

The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers.

C. Forbes, G. Houin, M. Mclaren, 1991, British journal of clinical pharmacology.

Elevated soluble cell adhesion molecules E-selectin and intercellular cell adhesion molecule-1 in type-2 diabetic patients with and without asymptomatic peripheral arterial disease.

R. Jung, T. Elhadd, G. Kennedy, 2004, International angiology : a journal of the International Union of Angiology.

Effect of nifedipine on changes in fibrinogen and von Willebrand factor in haemodialysis patients treated with recombinant human erythropoietin

M. Mclaren, W. K. Stewart, J. Belch, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Elevated levels of soluble E-selectin in diabetic patients with severe symptomatic peripheral arterial occlusive disease requiring angioplasty. A possible role in diabetic vascular disease?

T. Elhadd, G. Kennedy, M. Mclaren, 2000, International angiology : a journal of the International Union of Angiology.

Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.

C. Lau, J. Thompson, M. Mclaren, 1993, British journal of clinical pharmacology.

Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.

C. Forbes, M. Mclaren, J. Belch, 1991, Cardiovascular research.

Evaluation of a combined laser Doppler flowmetry and iontophoresis technique for the assessment of equine cutaneous microvascular function.

B. McGorum, M. Mclaren, F. Khan, 2010, Equine veterinary journal.

Development of a radioimmunoassay for the measurement of prostacyclin metabolites in unextracted plasma.

C. Forbes, M. Mclaren, J. Belch, 1985, Thrombosis research.

Circadian variation of endothelial cell function, red blood cell deformability and dehydro‐thromboxane B2 in healthy volunteers

M. Mclaren, J. Belch, A. Bridges, 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Soluble P-selectin assay: importance of correct anticoagulant choice.

M. Mclaren, J. Belch, G. Kirk, 1997, Platelets.

The white blood cell and plasma fibrinogen in thrombotic stroke. A significant correlation.

A. Hill, M. Mclaren, J. Belch, 1998, International angiology : a journal of the International Union of Angiology.

Maitotoxin increases voltage independent chloride and sodium currents in GH4C1 rat pituitary cells.

R. Young, J. Ramsdell, M. Mclaren, 1995, Natural toxins.

Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers.

M. Mclaren, J. Belch, A. Bridges, 1992, Free radical research communications.

Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome.

C. Forbes, G. Lowe, D. Mikhailidis, 1985, Prostaglandins, leukotrienes, and medicine.

Reduced Prostacyclin Production by Umbilical Arteries from Pregnancy Complicated by Severe Pregnancy Induced Hypertension

C. Forbes, I. Greer, M. Mclaren, 1987 .

MEASUREMENT OF PROSTACYCLIN METABOLITES

C. Forbes, I. Greer, M. Mclaren, 1983, The Lancet.

The beneficial effects of omega-3 and omega-6 essential fatty acid supplementation on red blood cell rheology.

M. Mclaren, J. Belch, C. Maple, 1999, Prostaglandins, Leukotrienes and Essential Fatty Acids.

Thepharmacokinetics ofdermatan sulphate MF701inhealthy humanvolunteers

C. Forbes, G. Houin, M. Mclaren, 1991 .

No effect of endotoxin on platelet aggregation.

M. Mclaren, J. Belch, I. Mackay, 1993, Platelets.

Letters

R. Newton, T. Elhadd, M. Mclaren, 1999, Diabetic medicine : a journal of the British Diabetic Association.